Amyloid-related imaging abnormalities (ARIA) found in approximately 40% of patients taking “Alzheimer’s drug” Aduhelm

By SharpBrains | November 29, 2021

Study: Biogen’s Aduhelm Caused Brain Swelling in Over One-Third of Study Par­tic­i­pants (Bio­Space): Atten­tion is being focused on a side effect of Biogen’s Alzheimer’s drug, Aduhelm (adu­canum­ab). Even before its con­tro­ver­sial approval on June 7, there were cas­es of amy­loid-relat­ed imag­ing abnor­mal­i­ties (ARIA‑E), or cere­bral ede­ma, observed in the trials.

Read More

Next: Brain scans to identify children at high risk of developing multiple sclerosis (MS) before symptoms appear

By SharpBrains | October 18, 2017

______________________________ MS risk in chil­dren spot­ted with MRI brain scans (Yale News): “By the time mul­ti­ple scle­ro­sis (MS) is diag­nosed in chil­dren, it may be dif­fi­cult to pre­vent the dis­abil­i­ties and relaps­es that come with the dis­ease. In a new Yale School of Med­i­cine study, researchers exam­ined MRI brain scans to iden­ti­fy chil­dren at high risk…

Read More